Suppr超能文献

设定比较效益研究的优先顺序:从评估公共卫生效益到向公众公开。

Setting priorities for comparative effectiveness research: from assessing public health benefits to being open with the public.

机构信息

National Pharmaceutical Council, Washington, DC, USA.

出版信息

Health Aff (Millwood). 2011 Dec;30(12):2235-42. doi: 10.1377/hlthaff.2011.0136.

Abstract

Medicine's current evidence base is insufficient for many of the decisions made daily by clinicians, patients, purchasers, and policy makers. The Patient-Centered Outcomes Research Institute represents an effort by the US government to address this shortcoming by funding comparative effectiveness research. Prioritizing that research will be a critical first step. To better understand components of an optimal process, we reviewed the literature and conducted interviews regarding the prioritization efforts of leading public and private health organizations in the United States and abroad. From this review, we propose a framework for prioritization, pose and answer key questions, and make recommendations regarding application of that framework. We also recommend that during the priority-setting process, there should be transparent conversations among those who make decisions about the priorities and the public.

摘要

目前,医学的证据基础还不足以支持临床医生、患者、购买者和政策制定者每天做出的许多决策。美国政府通过资助比较效果研究,努力通过患者为中心的成果研究所来解决这一不足。优先考虑这项研究将是至关重要的第一步。为了更好地了解最佳流程的组成部分,我们回顾了文献,并就美国和国外主要公共和私人卫生组织的优先排序工作进行了访谈。通过这项审查,我们提出了一个优先排序框架,提出并回答了关键问题,并就该框架的应用提出了建议。我们还建议,在确定优先次序的过程中,决策者和公众之间应该进行透明的对话。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验